Loading…
Star Imaging and Path Lab (BSE 544482)₹72.00−2.70%Healthcare Service Provider
In the Mar 2026 quarter (consolidated), Star Imaging and Path Lab reported sales of ₹43.07 Cr, up 4.8% from Mar 2025, and net profit of ₹9.04 Cr, down 10.0% year on year. For the year to Mar 2026, sales were ₹89.14 Cr and net profit ₹19.08 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 43.05 | 41.09 | 45.09 | 43.07 |
| Expenses | 30.99 | 23.99 | 28.01 | 27.01 |
| Operating Profit | 12.04 | 17.06 | 17.05 | 16.06 |
| OPM % | 27.1% | 41.1% | 38.0% | 37.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.99 |
| Interest | 0.99 | 0.99 | 0.99 | 0.99 |
| Depreciation | 1.99 | 3.01 | 3.01 | 3.01 |
| Profit before tax | 8.01 | 13.01 | 14.01 | 12.99 |
| Tax % | 25.0% | 26.0% | 26.0% | 28.0% |
| Net Profit | 6.02 | 10.04 | 10.04 | 9.04 |
| EPS (Rs) | 41.38 | 7.20 | 5.78 | 5.31 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 69.16 | 58.06 | 79.18 | 84.18 | 89.14 |
| Expenses | 53.97 | 51.99 | 54.96 | 53.99 | 55.01 |
| Operating Profit | 15.05 | 6.02 | 23.07 | 29.11 | 33.11 |
| OPM % | 21.0% | 10.0% | 30.0% | 35.1% | 37.0% |
| Other Income | 0.00 | 0.00 | 0.99 | 0.00 | 0.99 |
| Interest | 1.99 | 1.99 | 2.99 | 2.99 | 1.99 |
| Depreciation | 4.01 | 3.01 | 5.01 | 5.01 | 6.01 |
| Profit before tax | 8.99 | 0.99 | 15.99 | 21.01 | 25.98 |
| Tax % | 33.0% | 35.0% | 23.0% | 26.0% | 27.0% |
| Exceptional items | 0.00 | 0.00 | 0.75 | 0.00 | 0.00 |
| Net Profit | 6.02 | 1.01 | 12.05 | 16.07 | 19.08 |
| EPS (Rs) | 41.96 | 3.88 | 82.84 | 11.81 | 11.08 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 2.00 | 2.00 | 2.00 | 14.01 | 17.02 |
| Reserves | 17.05 | 17.04 | 30.10 | 34.10 | 99.20 |
| Borrowings | 30.03 | 26.99 | 31.04 | 32.98 | 20.99 |
| Other Liabilities | 10.05 | 16.08 | 20.09 | 18.09 | 17.08 |
| Total Liabilities | 58.13 | 61.11 | 82.23 | 98.18 | 154 |
| Fixed Assets | 15.02 | 19.03 | 22.05 | 21.04 | 25.06 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 43.11 | 42.08 | 60.18 | 77.14 | 128 |
| Inventories | 0.00 | 1.01 | 1.01 | 0.00 | 0.00 |
| Trade receivables | 15.99 | 17.97 | 32.97 | 50.89 | 49.89 |
| Cash & equivalents | 8.98 | 1.99 | 15.96 | 4.99 | 51.91 |
| Total Assets | 58.13 | 61.11 | 82.23 | 98.18 | 154 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 13.94 | 4.98 | 17.93 | −5.98 | 22.90 |
| Cash from investing activity | −3.98 | −6.97 | −6.97 | −3.99 | −12.95 |
| Cash from financing activity | −6.98 | −4.99 | 1.99 | 0.00 | 35.94 |
| Net cash flow | 3.01 | −6.99 | 12.99 | −10.01 | 45.99 |
| Capex | 4.29 | 7.31 | 8.46 | 4.23 | 10.26 |
| Free cash flow | 9.99 | −1.99 | 10.99 | −9.99 | 12.99 |
| CFO / OP % | 118.9% | 94.9% | 95.0% | −2.0% | 91.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 85 | 110 | 152 | 222 | 206 |
| Inventory days | — | — | — | — | 25 |
| Days payable | — | — | — | — | 398 |
| Cash conversion cycle | 85 | 110 | 152 | 222 | −167 |
| Working capital days | 6 | −13 | 23 | 121 | 142 |
| ROCE % | — | 6.0% | 34.0% | 35.0% | 26.0% |
For the Mar 2026 quarter, Star Imaging and Path Lab reported sales of ₹43.07 Cr, up 4.8% year on year and net profit of ₹9.04 Cr, down 10.0% year on year. The operating margin was 37.0%.
Star Imaging and Path Lab's sales for the year to Mar 2026 were ₹89.14 Cr.
Net profit for the year to Mar 2026 was ₹19.08 Cr. Earnings per share over the same trailing period were ₹11.08.
Star Imaging and Path Lab reported borrowings of ₹20.99 Cr at Mar 2026, against cash and equivalents of ₹51.91 Cr.
Cash from operations was ₹22.90 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹12.99 Cr.